Read news on Novo Nordisk with our app.
Read more in the app
Ozempic maker Novo Nordisk breach exposed patients’ clinical trial data
Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
